Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report

Hiromitsu Tabata; Akira Kuriyama; Fusae Yamao; Hiroshi Kitaguchi; Katsuro Shindo

doi:10.5664/jcsm.6600

Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report

J Clin Sleep Med. 2017 May 15;13(5):759-760. doi: 10.5664/jcsm.6600.

Authors

Hiromitsu Tabata¹, Akira Kuriyama², Fusae Yamao¹, Hiroshi Kitaguchi¹, Katsuro Shindo¹

Affiliations

¹ Department of Neurology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
² Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.

Abstract

Suvorexant is a new insomnia drug, and it is generally safe and well tolerated. Here, we report a rare but potentially important adverse effect of suvorexant in a patient with Parkinson disease.

Keywords: Parkinson disease; REM sleep behavioral disorder; nightmare; polysomnography; suvorexant.

Publication types

Case Reports

MeSH terms

Aged
Azepines / adverse effects*
Azepines / therapeutic use
Dreams / drug effects
Humans
Male
Parasomnias / chemically induced*
Parasomnias / complications
Parkinson Disease / complications*
Sleep Aids, Pharmaceutical / adverse effects*
Sleep Aids, Pharmaceutical / therapeutic use
Sleep Initiation and Maintenance Disorders / drug therapy*
Triazoles / adverse effects*
Triazoles / therapeutic use

Substances

Azepines
Sleep Aids, Pharmaceutical
Triazoles
suvorexant